Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ASCO CAR-T Highlights: Exploring New Frontiers For The Field

Jun 01 2017

• By Emily Hayes

T-cells attacking cancer_1200x675

Related Content

Keeping Track: US FDA Approvals Binge Continues With Dupixent, Ocrevus And Zejula; Two CAR-T Are Under Review

Apr 01 2017

Related Companies

Novartis AG

Johnson & Johnson

AbbVie Inc.

Kite Pharma, Inc.

University of Pennsylvania

Roche Holding AG

Merck & Co., Inc.

Bristol Myers Squibb Company

Additional Topics

ImmunoOncology Clinical Trials Research & Development Cancer BioPharmaceutical

More from Immuno-oncology

More from Anticancer

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window